Human platelet lysate current standards and future developments

Volume: 59, Issue: 4, Pages: 1407 - 1413
Published: Feb 11, 2019
Abstract
A state-of-the-art workshop focused on the use of human platelet lysate (HPL) for cell therapy. The meeting established that HPL is used mainly as an adjunct material for ex vivo expansion of mesenchymal stem/progenitor cells (MSCs), where it is successfully used as a substitute for fetal bovine serum. HPL manufacturing as a cell expansion supplement is currently not yet uniformly standardized with regard to platelet source and production...
Paper Details
Title
Human platelet lysate current standards and future developments
Published Date
Feb 11, 2019
Volume
59
Issue
4
Pages
1407 - 1413
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.